These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10449284)
1. Compartmentalization of the IgG immune response to HIV-1 in breast milk. Becquart P; Hocini H; Garin B; Sépou A; Kazatchkine MD; Bélec L AIDS; 1999 Jul; 13(11):1323-31. PubMed ID: 10449284 [TBL] [Abstract][Full Text] [Related]
2. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336 [TBL] [Abstract][Full Text] [Related]
3. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera. Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754 [TBL] [Abstract][Full Text] [Related]
4. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial. Gottardo R; Bailer RT; Korber BT; Gnanakaran S; Phillips J; Shen X; Tomaras GD; Turk E; Imholte G; Eckler L; Wenschuh H; Zerweck J; Greene K; Gao H; Berman PW; Francis D; Sinangil F; Lee C; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Tartaglia J; Robb ML; Michael NL; Kim JH; Zolla-Pazner S; Haynes BF; Mascola JR; Self S; Gilbert P; Montefiori DC PLoS One; 2013; 8(9):e75665. PubMed ID: 24086607 [TBL] [Abstract][Full Text] [Related]
5. Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women. Sacha CR; Vandergrift N; Jeffries TL; McGuire E; Fouda GG; Liebl B; Marshall DJ; Gurley TC; Stiegel L; Whitesides JF; Friedman J; Badiabo A; Foulger A; Yates NL; Tomaras GD; Kepler TB; Liao HX; Haynes BF; Moody MA; Permar SR Mucosal Immunol; 2015 Mar; 8(2):316-26. PubMed ID: 25100291 [TBL] [Abstract][Full Text] [Related]
6. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820 [TBL] [Abstract][Full Text] [Related]
7. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network. Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607 [TBL] [Abstract][Full Text] [Related]
8. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk. Nelson CS; Pollara J; Kunz EL; Jeffries TL; Duffy R; Beck C; Stamper L; Wang M; Shen X; Pickup DJ; Staats HF; Hudgens MG; Kepler TB; Montefiori DC; Moody MA; Tomaras GD; Liao HX; Haynes BF; Ferrari G; Fouda GGA; Permar SR J Virol; 2016 May; 90(10):4951-4965. PubMed ID: 26937027 [TBL] [Abstract][Full Text] [Related]
9. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides. Neurath AR; Strick N; Lee ES J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372 [TBL] [Abstract][Full Text] [Related]
10. The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells. Jeffries TL; Sacha CR; Pollara J; Himes J; Jaeger FH; Dennison SM; McGuire E; Kunz E; Eudailey JA; Trama AM; LaBranche C; Fouda GG; Wiehe K; Montefiori DC; Haynes BF; Liao HX; Ferrari G; Alam SM; Moody MA; Permar SR Mucosal Immunol; 2016 Mar; 9(2):414-27. PubMed ID: 26242599 [TBL] [Abstract][Full Text] [Related]
11. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk. Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR J Virol; 2017 May; 91(9):. PubMed ID: 28202762 [TBL] [Abstract][Full Text] [Related]
12. Detection of IgA-binding sites on human immunodeficiency virus type-1 envelope glycoproteins, Gp120 and Gp41. Matsuda S; Noda M Microbiol Immunol; 2000; 44(11):923-9. PubMed ID: 11145273 [TBL] [Abstract][Full Text] [Related]
13. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932 [TBL] [Abstract][Full Text] [Related]
14. Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41. Burrer R; Haessig-Einius S; Aubertin AM; Moog C Virology; 2005 Mar; 333(1):102-13. PubMed ID: 15708596 [TBL] [Abstract][Full Text] [Related]
15. Maternal antibodies to HIV-1 envelope domains: No correlation with HIV-1 vertical transmission in patients from Argentina. Calarota SA; Libonatti OV Scand J Immunol; 2000 Sep; 52(3):292-7. PubMed ID: 10972906 [TBL] [Abstract][Full Text] [Related]
16. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1. Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599 [TBL] [Abstract][Full Text] [Related]
17. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea. Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286 [TBL] [Abstract][Full Text] [Related]
18. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells. Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650 [TBL] [Abstract][Full Text] [Related]
19. Induction of HIV-1 MPR(649-684)-specific IgA and IgG antibodies in caprine colostrum using a peptide-based vaccine. Dorosko SM; Ayres SL; Connor RI Vaccine; 2008 Oct; 26(42):5416-22. PubMed ID: 18708113 [TBL] [Abstract][Full Text] [Related]
20. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. Hocini H; Bélec L; Iscaki S; Garin B; Pillot J; Becquart P; Bomsel M AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1179-85. PubMed ID: 9310284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]